GenScript Partners With Tamarind Bio to Speed AI Drug Discovery Validation
GenScript and Tamarind Bio have partnered to connect AI-powered molecular design with wet-lab validation, aiming to help researchers evaluate drug candidates faster.
Where global leaders learn how AI shapes business, technology and society
GenScript and Tamarind Bio have partnered to connect AI-powered molecular design with wet-lab validation, aiming to help researchers evaluate drug candidates faster.
The appointment comes as the company expands its use of artificial intelligence across clinical research and drug development workflows.
"I look forward to partnering with our teams around the world to deliver greater value for customers facing increasingly complex challenges."
The new ShipBob MCP offers 70+ read and write actions across 10 areas of operations, among the first full read-write connectors in the fulfillment industry.
"BioCatch will help our clients stop fraud before it reaches the point of payment."
GE HealthCare introduced new AI-enabled ultrasound platforms for breast imaging and point-of-care care, expanding automation across screening, diagnosis, and clinical imaging.
Palantir's strongest quarter yet came with a bigger claim: enterprises want to own more of the AI they deploy.
Minimum triple-digit growth sets the company’s AI orders to surge from ~$25M in FY25 to at least $100M by FY27.
"Together, we can help clients bridge the gap between innovation and execution, turning AI potential into measurable business results."
The mechanism is already used by roughly half of US adults with a bank account.
Apple used its latest earnings call to argue that some enterprise AI workloads are better suited to run on endpoint devices, while continuing to rely on the cloud for others.
"A verified mechanism should exist before AI systems reach a point where they can accelerate their own development faster than humans can supervise."
Providence is using AI to identify cancer patients who may benefit from genetic testing, helping detect inherited cancer risks earlier and improve treatment decisions.
The company said Airo's annualized bookings run rate climbed to $50 million in the second quarter, up from $10 million just one quarter earlier.
"Users of MAX through the chat interface are more likely to explore advanced MAX features."
Pega bets enterprise AI needs less reasoning at runtime, not more, and prices accordingly.
"This firm quietly underpins the global financial system, at a scale most people never fully appreciate."
"We continue to invest in digital tools that make shopping simpler, more intuitive and more convenient for our customers."
Labcorp's Q2 results show AI is supporting consumer health, specialty diagnostics, and clinical research as the company raises its 2026 outlook.
"We are revolutionizing how clients engage with research and advisory firms."